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Abstract. This study reports the geographical incid-
ence of successful pregnancies in women on renal
replacement therapy (RRT) and related information
on gestation and clinical status of newborns. The
impact of successful pregnancy on graft function was
assessed by means of a retrospective case-control
study.
Since 1977 special questionnaires have been sent
to each dialysis and transplant centre which reported
babies born to mothers on RRT on the yearly centre
questionnaire. After 10 years of data collection, a
total of 490 pregnancies and 500 babies were available
for analysis. A percentage of 88.4 of the babies were
born to mothers with a functioning graft, 11.2% to
mothers on chronic haemodialysis, and the remaining
0.4% to mothers on CAPD.
Almost 50% of all successful pregnancies were
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reported from the UK. The number of successful
pregnancies increased steadily and in parallel with
the increasing number of females of childbearing age
with a functioning renal transplant. The majority of
mothers delivered at age 24-32. For transplanted
mothers delivery occurred most commonly during the
3rd and 4th year after successful transplantation.
In approximately 85% of cases the duration of
pregnancy was shorter than the lower 10th percentile
of normal. Birthweight was reduced in accordance
with gestational age. Newborn mortality was 1.8%.
Fifty-three mothers with a successful pregnancy in
1984 1987 were computer matched with controls
according to a number of criteria. The serum creatin-
ine concentration recorded in coded form at the end
of each year on the individual EDTA patient question-
naire was used to assess changes in graft function. In
94% of these cases the serum creatinine, recorded
0 11 months before delivery, did not exceed
160 umol/1. Graft function deteriorated in 18% of
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mothers as compared to 24% of controls. Twenty-
four to 36 months postpartum, changes of serum
creatinine were similar in test cases and controls,
suggesting that a successful pregnancy does not
adversely affect graft function if this was stable and
well preserved at the time of conception.
Key words: renal replacement therapy; pregnancy;
newborns
Introduction
Successful renal transplantation is considered to be
by far the best renal replacement therapy for patients
in end-stage renal failure (ESRF). Transplantation
activity and outcome continue to improve such that
an increasing proportion of women in ESRF and of
childbearing age now recover a normal reproductive
function. For these women there is no doubt that
successful pregnancy can be considered a sign of
excellent rehabilitation from the original disease.
The reports on pregnancies in women after renal
transplantation are quite numerous [1-17] but mainly
describe the experience obtained in single centres and
therefore relate to a relatively small number of cases.
The main problems that have to be considered in
transplanted women who wish to become pregnant
are the potential risks to the fetus (survival, mal-
formations) and the potential risks to the mother
(survival, graft function). Given the relatively small
number of successful pregnancies observed in each
single centre, it is unlikely that statistically valid
answers to these important questions can be derived
from single-centre studies. In contrast, analysing the
data collected on a large number of pregnancies over
many years from all countries reporting to the EDTA
Registry would be expected to yield answers regarding
the general risk and other important aspects of preg-
nancy in mothers on RRT.
The purpose of this ongoing study is to evaluate
the geographical distribution and the annual incid-
ence of successful pregnancies in Europe and to
collect information on the newborns and their sur-
vival at 1 month of life. It was also thought to be
useful to evaluate the impact of pregnancy on graft
function by means of a retrospective case-control
study.
Subjects and methods
Demographic study
Since 1977 the EDTA Registry has paid special attention
to those successful pregnancies which occurred in women
on renal replacement therapy (RRT). Special questionnaires
have been sent to each centre that reported one or more
babies born to mothers on RRT on the yearly centre
questionnaire. The first version of the special questionnaire
is shown in Figure 1A. It was made simpler (Figure IB)
in 1984 by deleting the questions on breastfeeding, chromo-
some examination, drugs during pregnancy, body length,
B
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Fig. 1. The special questionnaire used 1977-83 (A) and since 1984 (B).
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and head circumference. By the end of 1986, that is after
10 years, data on a total of 490 pregnancies and 500 babies
were available for analysis (results on a smaller number of
newborns were published earlier [18,19]).
Retrospective case-control study
Transplanted mothers with a successful pregnancy between
November 1984 and January 1987 were identified on the
EDTA Registry's patient files. Each of these test case
mothers with a successful pregnancy was then matched by
computer with a control case according to the following
criteria: the test cases and controls had to come from the
same country, to have received their first graft in the same
year and from the same type of donor, and had to have
identical codes for plasma creatinine concentration prior
to the date of pregnancy. Control grafts had to be func-
tioning at the date of the delivery of their respective test
cases. The fully matched pairs (40 pairs) were female with
a primary renal disease belonging to the same group of
renal diseases. In a minority of controls (13 pairs) a
difference in sex (6 pairs) and primary renal disease group
(7 pairs) had to be accepted. However, the results obtained
in the fully matched pairs were identical to those for pairs
mismatched for sex and/or for primary renal disease group.
For this reason all 53 case control pairs identified were
included in the analyses shown below.
The concentration of plasma creatinine, as recorded in
coded form at the end of each year for every patient with
a functioning graft, was used to assess the impact of
pregnancy on graft function.
Results
Among the 500 newborns reported to the EDTA
Registry from 1977 to 1986 there were eight sets of
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twins and one set of triplets. The great majority of
the newborns (88.4%) were born to mothers with a
functioning graft; in only 11.2% and 0.4% of the
cases the mothers were on long-term haemodialysis
or CAPD respectively.
Demographic study
The country where most of the successful pregnancies
occurred was the UK, which accounted for almost
50% of them; in countries like Italy or FRG only
0.5% or less of transplanted women of child bearing
age had successful pregnancies. The number of suc-
cessful pregnancies reported to the Registry each year
steadily increased from 1977 to 1986, in parallel with
the increasing number of renal transplants in Europe.
This is shown in Figure 2 by the number of females
with successful pregnancies as a proportion of all
females with a functioning graft aged 17-40 in nine
European countries. These proportions remained
unchanged comparing the period 1977-1981 with
1982-1986. Two-thirds of the mothers were between
24 and 32 years old at the time of delivery (Figure 3);
only a few successful pregnancies occurred in patients
aged less than 21 and more than 40 years. Some 40%
of deliveries took place during the 3rd and 4th year
after transplantation (Figure 4), with a small percent-
age reported during the first year or as late as nine
or more years after transplantation.
The length of gestation for babies born to women
on RRT was much shorter than in the normal
population (Figure 5); only 50% of babies had a
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Fig. 2. Successful pregnancies in Europe in 1977-81 and 1982-86 as a proportion of all females with a functioning graft aged 17-40 at
end of 1981 or 1986.
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Fig. 3. Proportional distribution of women with successful pregnancies according to age at delivery.
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Fig. 4. Time in years from graft to delivery shown as a proportion of transplanted women who had successful pregnancies Nearly half
of the deliveries occurred between 2 and 5 years after grafting.
pregnancy of the normal 37 or more weeks duration
compared with 90% in the general population.
Figure 6 shows the distribution of birthweights of
these same newborns compared with the distribu-
tion in the general population. It is worth noting
that the majority of the babies born to mothers on
dialysis were smaller than those born to mothers with
a functioning renal transplant. The relationship
between gestational age and birth weight was deter-
mined for babies born to mothers on RRT in 1983
(Figure 7); almost all fell between the 10th and 90th
percentile for the normal population [18], suggesting
that these newborns were small mainly because they
were premature.
Nine newborns died during the first month of life
(1.8%), and eight of them had a birth weight of less
than 1.8 kg. The reported causes of death were acute
respiratory distress syndrome (3), sudden unexplained
death (2), 'malformation' (2), intracerebral haemor-
rhage (1), and prolapsed cord (1).
The detailed list of malformations reported on the
questionnaires is given in Table 1; none of these
malformations could be attributed to chromosomal
causes, one case was monogenic (0.4%), and 11 cases
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Fig. 6. Distribution of birth weights of 484 babies born to women on renal replacement therapy. Information on birth weight in the
normal population is given for comparison.
appeared to be multifactorial (2.2%). In each category
the number observed was within the limits expected
for the newborn population.
Case-control study
From Table 2 it can be seen that 94% of all the
transplanted women who had a successful pregnancy
had a plasma creatinine concentration of 160 umol/1
or less (creatinine code 1 or 2) 0-11 months prior to
pregnancy. Only three test cases, the remaining 6%,
had a higher pre-pregnancy plasma creatinine
recorded 1-4 months before the presumed time of
conception. This clearly demonstrates that in this
series, women who achieved a successful pregnancy
usually had a normal or only slightly reduced graft
function prior to gestation.
Figure 8 gives two examples of the relationship
between the availability of plasma creatinine codes
and gestation. Creatinine concentrations at the end
of December of each year are recorded on the EDTA
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Fig. 7. Birth weights of babies born to mothers on renal replace-
ment therapy in 1983 according to gestational age
Table 1. Congenital abnormalities reported to the Registry in 500
newborns
Congenital heart defect
Unnary tract malformation
Hypospadias
Gastrointestinal tract abnormalities
(Hirschsprung, oesosphageal atresia,
anal atresia, hernias)
CNS abnormalities
(spina bifida, plagiocephaly,
agenesia corporis callosi)
Cranial abnormalities
(choanal atresia, cleft lip and palate)
Haemangioma frontalis
Medullary cystic disease
Bilateral clubfoot
Bilateral cataract
Pigeon chest and agenesis of thumb
Other
Only 2 vessels in umbilical cord
'Congenital cytomegaly'
Phenytoin syndrome
(1 associated with
oesophageal atresia)
3
2
In two cases the answer to the question on the presence of neonatal
malformations was 'yes' but no specifications were given.
Table 2. Number and proportion of patients according to creatinine
level before pregnancy. The time interval between the recorded
serum creatinine and start of pregnancy ranged from 0 to 11
months
Code
1
2
3
4
5
6
7
umol 1
<I2O
121-160
161-200
201-240
241-300
301-400
>400
n
36
14
1
1
I
%
»
26-
.1
2.
—
2
B ' B t f o r t 4.7 (0-11)
A . A f l t r 5JII-IH
Fig. 8. Mean number (range) of months between the recorded
serum creatinine and the beginning of pregnancy (B = before) and
between the end of pregnancy and the next recorded serum
creatinine (A = after),
patient questionnaire, as indicated by the arrows.
Gestation could occur during a single calendar year
(for example during 1985) and in this case the
recorded creatinine used to evaluate renal function
would be close in time both to the start of the
pregnancy and to delivery. If the gestation took place
during two calendar years (e.g. conception in 1984
and delivery in 1985) the time gap between the
reported creatinine codes and gestation would be
wider. Given these two possible situations for the 53
pairs included in the study, the average number of
months between the nearest recorded creatinine and
the beginning of pregnancy was 4.7 months (range
0-11 months) and 5.3 months (range 1-11 months)
between delivery and the next available creatinine.
Figure 9 shows the results of the comparison
between creatinine codes before and immediately
following a successful pregnancy in test cases and in
the matched controls for the same period. Creatinine
codes indicated stable (or improved) graft function
in both test and control cases in 67% of the pairs.
In 9% of the pairs the test case became worse but
the control did not; in 15% the control deteriorated
contn
control wont
case + control wont
9%
S3 pain
Fig. 9. Graft function according to creatinine level after successful
pregnancy for cases and in controls as compared to graft function
prior to pregnancy.
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but the test case did not; in the remaining 9% renal
function for both the test and the control cases
deteriorated.
To see whether pregnancy produced an ad\erse
effect on renal function during the later follow-up
after delivery, the average value of the creatinine
codes available for 42 pairs at 13 20 months and for
15 pairs at 25 35 months after delivery were calcu-
lated. The average value of the creatinine codes
tended to increase (i.e. deteriorate) with time, both
in the test and in control cases. However, test cases
did not deteriorate more than the controls (Figure 10).
There was a single mother who lost her graft 31
months after delivery, compared to five control cases
with graft failure recorded at 7-31 months after date
of delivery of the respective test cases.
Discussion
For a woman with a functioning graft to undergo a
successful pregnancy is the best possible proof of
'rehabilitation' from ESRF. Many authors have
reported the experience accumulated in their own
centres [21,22] and have reviewed the literature
[23-26] on this subject. Successful pregnancies in
transplanted women have never been studied extens-
ively in a uniform way on a European scale. The
EDTA Registry has paid special attention to this
important subject since the seventies and has collected
information on one of the largest series ever analysed.
From the present study it is clear that the only
problem for the newborns is prematurity and there-
fore a low birth weight, with the potential risks that
this condition implies [24]. This study with its larger
series also confirms that conventional immunosuppr-
ession (azathiopnne and prednisone) does not result
in more malformations evident at birth than seen in
the normal population [19,20]. Preliminary data col-
lected more recently by the EDTA Registry on 35
babies born to mothers on cyclosporin [27] do not
suggest a higher incidence of malformations. Data
on chromosome studies for a large number of such
newborns are still missing. In this respect, chromo-
some studies reported to the first version of the EDTA
questionnaire concerning 16 babies gave normal
results in 14 and chromatid breaks, which are known
to be reversible, in 2 [19,20]. Only 29 of 186 (16%)
babies born between 1979 and 1982, reported on
earlier, were breastfed by their mothers [20].
The mortality rate of 1.8% in these newborns may
be an underestimation because it only refers to the
first month of life and therefore does not include
deaths after this period. It has to be recalled that the
present study does not give any information on 'non-
successful pregnancies', so that the total number of
pregnancies initiated in this population is not known
nor are the causes of miscarriage. Also, since informa-
tion is not available, no conclusions can be drawn
regarding potential late effects of immunosuppression
in the mothers, which might emerge in their offspring
after many months or years.
The present study clearly shows that successful
pregnancies in women with a functioning transplant
vary markedly in incidence among European coun-
tries. Moreover, the proportion of transplanted
women of childbearing age who had a successful
pregnancy did not increase from the mid-seventies to
Cases • Controls
53 pairs 53 pairs 42 pairs 15 pain.
Creatinine
code
before
pregnancy
1-11 13-20 25-35
months after delivery
Fig. 10. Mean of creatinine codes before and after successful pregnancy and in controls with a functioning graft. Graft failure was
recorded for one case 31 months after delivery and for five controls 7 31 months after their respective case's date of delivery
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the mid-eighties. This clearly means that the attitude
of the patients, of their families, and of the nephrolog-
ists regarding pregnancy in these subjects must differ
from country to country. It is very likely that it is
the medical attitude and belief which carry the great-
est influence. No change over time in the proportion
of transplanted mothers with successful pregnancies
(Figure 2) could mean that it is always the same
centres and doctors that have been in favour of a
pregnancy, whilst the great majority probably have
not supported, or have even discouraged, pregnancy
in transplanted women. This majority of doctors, and
consequently also their patients, still might consider
pregnancy to be a risk for the graft function. It is
also possible to imagine that in cases where trans-
plantation had been awaited for a long time and had
been experienced as a 'miracle' more than as a
therapeutic procedure, the patient's expectations were
fulfilled to the extent that she would not want to run
any additional risk to her graft. This is all the more
so as pregnancy has often been accused of adversely
affecting graft function in a sizeable proportion of
mothers [5,13,25].
In an earlier analysis of successful pregnancies, the
Registry came to the conclusion that up to 17% of
grafted mothers might suffer damage to their graft,
with loss of graft function or even graft failure in
association with the pregnancy [20]. However, other
authors put forward the hypothesis that pregnancy
could be considered to be relatively safe in women
with a well-functioning graft [26,28]. Given the small
number of pregnancies in transplanted women, the
information available in the literature on the impact
of successful pregnancy on graft function is limited
and had never been studied by means of a comparison
with a matched population in which there will always
be found some individuals who lose renal function
because of immunological or other causes.
For all of these reasons we decided to perform a
retrospective case-control study. The results confirm
that almost all women who had a successful preg-
nancy had a well-functioning graft beforehand. The
number of mothers who suffered some decline in
graft function, or who lost the graft, during a period
of up to 3 years after deli%'ery was certainly not
greater than in the retrospectively matched control
group which incurred a similar or greater loss of graft
function without pregnancy. The results of the present
analysis thus suggest that in general a successful
pregnancy rarely if ever has a deleterious effect on
graft function when this was normal or close to
normal at the time of conception. It must be stressed
that this study does not give any information on
long-term evolution beyond 3 years after delivery,
and on the impact of pregnancy in women with
clearly abnormal graft function at the time of concep-
tion. The impact of 'non-successful pregnancies' on
the graft function still remains to be elucidated
Earlier attempts by the EDTA Registry to collect
data on abortions and stillbirths had to be aban-
doned. Such cases do not come to the attention of
the Registry as the special pregnancy questionnaires
have been sent exclusively to centres reporting "live
babies born to mothers on RRT'.
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